Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid
- 1 March 1980
- journal article
- research article
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 52 (1-2) , 45-50
- https://doi.org/10.1007/bf01400945
Abstract
Tranexamic acid as an antifibrinolytic agent has been investigated in a controlled study in patients with recent subarachnoid haemorrhage. It is concluded that tranexamic acid improves neither rebleeding rates, nor mortality. Predominantly thrombotic complications have been noted as a more serious side effect of tranexamic acid.This publication has 26 references indexed in Scilit:
- THE USE OF ANTIFIBRINOLYTIC DRUGS TO PREVENT EARLY RECURRENT ANEURYSMAL SUBARACHNOID HAEMORRHAGEActa Neurologica Scandinavica, 2009
- Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: A double‐blind controlled clinical trialAnnals of Neurology, 1977
- E-AMINOCAPROIC ACID AND SUBARACHNOID HÆMORRHAGEThe Lancet, 1974
- Arteriopathic complications during treatment of subarachnoid hemorrhage with epsilon-aminocaproic acidJournal of Neurosurgery, 1974
- Monitoring antifibrinolytic therapy in subarachnoid hemorrhageJournal of Neurosurgery, 1973
- The use of antifibrinolytic substances in ruptured intracranial aneurysmsmin - Minimally Invasive Neurosurgery, 1969
- ROLE OF UROKINASE AND TISSUE ACTIVATOR IN SUSTAINING BLEEDING AND THE MANAGEMENT THEREOF WITH EACA AND AMCAAnnals of the New York Academy of Sciences, 1968
- Antifibrinolytic Therapy for Intracranial AneurysmsJournal of Neurosurgery, 1968
- Natural History of Subarachnoid Hemorrhage, Intracranial Aneurysms and Arteriovenous MalformationsJournal of Neurosurgery, 1966
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957